|
|
Other links at Articles > Allergy and Clinical Immunology |
| 3. |
Mepolizumab of Little Help to Most Asthmatics
|
|
|
Mepolizumab, a humanized anti-interleukin-5 monoclonal antibody, does not appear to give additional benefit to the majority of patients whose asthma is incompletely controlled by corticosteroid therapy, UK and US researchers report. Reuters Health Information
|
|
|